QuiVad

Home / Germany / Medigene AG

Medigene AG

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 2.74% on November 29, 2017. The shaded band matches the twelve months of the first chart.

December 1, 2016 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Medigene AG by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

109 disclosures on record for this share.
DateFund% of capitalEnd of publication
December 1, 2017Voleon Capital Management LP0.66%
November 29, 2017Citadel Advisors II LLC1.17%
November 29, 2017Voleon Capital Management LP0.77%
November 27, 2017Citadel Advisors II LLC1.25%
November 23, 2017Citadel Advisors II LLC1.15%
November 22, 2017Citadel Advisors II LLC0.94%
November 20, 2017Citadel Advisors II LLC1.07%
November 17, 2017Citadel Advisors II LLC1.10%
November 15, 2017Citadel Advisors II LLC1.04%
November 13, 2017Citadel Advisors II LLC0.70%
November 9, 2017Oxford Asset Management0.80%
November 2, 2017Citadel Advisors II LLC0.64%
October 26, 2017Oxford Asset Management0.71%
October 24, 2017Voleon Capital Management LP0.56%
October 23, 2017Voleon Capital Management LP0.61%
October 19, 2017Citadel Advisors II LLC0.57%
October 18, 2017Citadel Advisors II LLC0.48%
October 17, 2017Voleon Capital Management LP0.54%
October 5, 2017Voleon Capital Management LP0.60%
September 29, 2017Voleon Capital Management LP0.57%
September 28, 2017Voleon Capital Management LP0.62%
September 28, 2017Citadel Advisors II LLC0.54%
September 27, 2017Voleon Capital Management LP0.77%
September 26, 2017Voleon Capital Management LP0.89%
September 25, 2017Voleon Capital Management LP1.00%
September 25, 2017Oxford Asset Management0.60%
September 22, 2017Voleon Capital Management LP1.12%
September 20, 2017Citadel Advisors II LLC0.68%
September 19, 2017Voleon Capital Management LP1.22%
September 15, 2017Voleon Capital Management LP1.15%
September 14, 2017Voleon Capital Management LP1.08%
September 13, 2017Voleon Capital Management LP0.98%
September 11, 2017Voleon Capital Management LP0.82%
September 8, 2017Voleon Capital Management LP0.72%
September 7, 2017Voleon Capital Management LP0.61%
September 7, 2017Oxford Asset Management0.51%
September 6, 2017Voleon Capital Management LP0.52%
September 4, 2017Citadel Advisors II LLC0.78%
September 1, 2017Citadel Advisors II LLC0.85%
August 21, 2017Citadel Advisors II LLC0.91%
August 14, 2017Citadel Advisors II LLC0.85%
August 8, 2017Citadel Advisors II LLC0.74%
August 3, 2017Citadel Advisors II LLC0.63%
July 10, 2017Citadel Advisors II LLC0.51%
July 7, 2017Citadel Advisors II LLC0.49%
July 6, 2017Citadel Advisors II LLC0.50%
June 22, 2017Citadel Advisors II LLC0.49%
June 22, 2017Voleon Capital Management LP0.49%
June 21, 2017Voleon Capital Management LP0.59%
June 16, 2017Citadel Advisors II LLC0.57%

Download 109 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Germany

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Medigene AG, source Bundesanzeiger, data as at April 2, 2019, https://www.quivad.com/action/medigene-ag?page=2